Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 12/2014

01-11-2014 | Endocrine Tumors

Surgeon and Staff Radiation Exposure During Radioguided Parathyroidectomy at a High-Volume Institution

Authors: Sarah C. Oltmann, MD, Andrew V. Brekke, Jose D. Macatangay, MS, David F. Schneider, MD, MS, Herbert Chen, MD, Rebecca S. Sippel, MD

Published in: Annals of Surgical Oncology | Issue 12/2014

Login to get access

Abstract

Introduction

Radioguided parathyroidectomy (RGP) uses technetium-99 m sestamibi causing gamma ray emission during RGP to aid dissection and confirm parathyroid excision. Source (the patient) proximity and exposure duration determine degree of exposure. The purpose of this study was to quantify surgeon and staff radiation exposure during RGP.

Methods

Surgeons and assistants wore radiation dosimeters during RGP procedures at a high-volume endocrine surgery practice. Area dosimeters measured personnel potential exposure. Data were prospectively collected. Provider exposures were corrected for both duration of exposure and case volume. Institutional safety requirements uses 100 mrem/year as an indicator for radiation safety training, 500 mrem/year for personal monitoring, and a maximum allowed exposure of 4,500 mrem/year.

Results

A total of 120 RGP were performed over 6 months. Badges were worn in 82 cases (68 %). Three faculty and four assistants were included. Primary hyperparathyroidism was the diagnosis for 95 %. Median case volume per provider was 13 cases (range 6–45), with median exposure of 18 h (range 9–70). Mean provider deep dose exposure (DDE) was 22 ± 10 mrem. Corrected for exposure duration, mean DDE was 0.6 ± 0.2 mrem/h. Corrected for case volume, mean DDE was 0.8 ± 0.2 mrem/case. Anesthesia exposure was minimal, while mayo stand exposure was half to two thirds that of the surgeon and assistant. Based on institutional guidelines and above data, 125 RGP/year warrants safety training, 625 RGP/year warrants monitoring, whereas >5,600 RGP/year may result in maximum allowed radiation exposure to the surgeon.

Conclusions

Surgeon and staff radiation exposure during RGP is minimal. However, high-volume centers warrant safety training.
Literature
1.
Murray SE, Pathak PR, Pontes DS, et al. Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism. Surgery. 2013;154(6):1463–9.PubMedCrossRef
2.
Wang TS, Pasieka JL, Carty SE (2014). Techniques of parathyroid exploration at North American endocrine surgery fellowship programs: what the next generation is being taught. Am J Surg, 207(4), 527–32.PubMedCrossRef
3.
Nagar S, Reid D, Czako P, Long G, Shanley C (2012). Outcomes analysis of intraoperative adjuncts during minimally invasive parathyroidectomy for primary hyperparathyroidism. Am J Surg. 2012;203(2):177–81.PubMedCrossRef
4.
Chen H, Mack E, Starling JR. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242(3):375–80; discussion 380–3.PubMedPubMedCentral
5.
Oltmann SC, Chen H. Minimally invasive radioguided parathyroidectomy. Curr Surg Rep. 2013;1(1):1–6.CrossRef
6.
Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999;126(6):1023–9.PubMedCrossRef
7.
Noureldine SI, Abbas A, Tufano RP, et al. The impact of surgical volume on racial disparity in thyroid and parathyroid surgery. Ann Surg Oncol. Mar 17 2014.
8.
Saunders BD, Wainess RM, Dimick JB, Doherty GM, Upchurch GR, Gauger PG. Who performs endocrine operations in the United States? Surgery. 2003;134(6):924–31; discussion 931.PubMedCrossRef
9.
Nottmeier EW, Pirris SM, Edwards S, Kimes S, Bowman C, Nelson KL (2013). Operating room radiation exposure in cone beam computed tomography-based, image-guided spinal surgery: clinical article. J Neurosurg Spine. 2013;19(2):226–31.PubMedCrossRef
10.
Wenner DE, Whitwam P, Turner D, Kennedy K, Hashmi S (2005). Actual time required for dynamic fluoroscopic intraoperative cholangiography. JSLS. 2005;9(2):174–7.PubMedPubMedCentral
11.
Bartal G, Vano E, Paulo G, Miller DL (2014). Management of patient and staff radiation dose in interventional radiology: current concepts. Cardiovasc Interv Radiol. 2014;37:289–98.
12.
Jorgensen JE, Rubenstein JH, Goodsitt MM, Elta GH (2010). Radiation doses to ERCP patients are significantly lower with experienced endoscopists. Gastrointest Endosc. 2010;72(1):58–65.PubMedCrossRefPubMedCentral
13.
Bronsard N, Boli T, Challali M, et al. (2013). Comparison between percutaneous and traditional fixation of lumbar spine fracture: intraoperative radiation exposure levels and outcomes. Orthop Traumatol Surg Res. 2013;99(2):162–8.PubMedCrossRef
14.
Ullery BW, Landau B, Wang GJ, Faifrman RM, Woo EY (2014). Radiation dose to the interventionalist is directly affected by the operating position. Vascular. 2014;22:149–53.
15.
Mohapatra A, Greenberg RK, Mastracci TM, Eagleton MJ, Thornsberry B. Radiation exposure to operating room personnel and patients during endovascular procedures. J Vasc Surg. 2013;58(3):702–9.PubMedCrossRef
16.
17.
Kristoffersen US, Straalman K, Schmidt G, et al. Radiation exposure to surgical staff during hyperthermic isolated limb perfusion with 99 m Technetium labeled red blood cells. Int J Hypertherm 2009;25(1):86–9.CrossRef
18.
Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33.PubMedCrossRefPubMedCentral
19.
McGhan LJ, McKeever SC, Pockaj BA, et al. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann Surg Oncol. 2011;18(11):3096–101.PubMedCrossRef
20.
Wong SL, Balch CM, Hurley P, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Ann Surg Oncol. 2012;19(11):3313–24.PubMedCrossRef
21.
Nejc D, Wrzesien M, Piekarski J, et al. Sentinel node biopsy in patients with breast cancer–evaluation of exposure to radiation of medical staff. Eur J Surg Oncol. 2006;32(2):133–8.PubMedCrossRef
22.
Nejc D, Wrzesien M, Piekarski J, et al. Sentinel node biopsy in skin melanoma patients–measurements of absorbed doses of radiation to the hands of medical staff. J Surg Oncol. 2006;93(5):355–61.PubMedCrossRef
23.
Bekis R, Celik P, Uysal B, et al. Exposure of surgical staff in surgical probe applications in radioguided parathyroidectomy. Eur Arch Otorhinolaryngol. 2008;265(12):1545–8.PubMedCrossRef
24.
Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery. 1997;122(6):998–1003; discussion 1003–4.PubMedCrossRef
25.
Chen H, Mack E, Starling JR. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg. 2003;238(3):332–7; discussion 337–8.PubMedPubMedCentral
26.
Chen H, Sippel RS, Schaefer S. The effectiveness of radioguided parathyroidectomy in patients with negative technetium tc 99 m-sestamibi scans. Arch Surg. 2009;144(7):643–8.PubMedCrossRef
27.
28.
Norman J, Politz D. 5,000 parathyroid operations without frozen section or PTH assays: measuring individual parathyroid gland hormone production in real time. Ann Surg Oncol. 2009;16(3):656–66.PubMedCrossRef
29.
Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery. 2007;142(6):887–99; discussion 887–99.PubMedCrossRef
30.
Rubello D, Al-Nahhas A, Mariani G, Gross MD, Rampin L, Pelizzo MR. Feasibility and long-term results of focused radioguided parathyroidectomy using a “low” 37 MBq (1 mCi) 99mTc-sestamibi protocol. Int Sem Surg Oncol. 2006;3:30.CrossRef
Metadata
Title
Surgeon and Staff Radiation Exposure During Radioguided Parathyroidectomy at a High-Volume Institution
Authors
Sarah C. Oltmann, MD
Andrew V. Brekke
Jose D. Macatangay, MS
David F. Schneider, MD, MS
Herbert Chen, MD
Rebecca S. Sippel, MD
Publication date
01-11-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 12/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3822-3

Other articles of this Issue 12/2014

Annals of Surgical Oncology 12/2014 Go to the issue

Head and Neck Oncology

The Importance of Surgical Volume on Outcomes in Thyroid Surgery Revisited: Old is in Again

Hepatobiliary Tumors

Clinicopathological and Prognostic Significance of Preoperative Serum Zinc Status in Patients with Hepatocellular Carcinoma After Initial Hepatectomy

Urologic Oncology

Concomitant Seminal Vesicle Invasion in pT4a Urothelial Carcinoma of the Bladder with Contiguous Prostatic Infiltration is an Adverse Prognosticator for Cancer-Specific Survival after Radical Cystectomy

Gynecologic Oncology

Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience

Head and Neck Oncology

What’s Old is New Again

Colorectal Cancer

The Diagnostic Value of One-Step Nucleic acid Amplification (OSNA) for Sentinel Lymph Nodes in Colon Cancer Patients